Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300180 · ClinicalTrials.gov registry record · NA
Caregiver Outcomes of Alzheimer's Disease Screening
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,822
- Enrollment target
NCT03300180 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,822 participants.
The verdict
NCT03300180, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,822 participants
- Enrollment target
Study Summary
This study will measure the risks and benefits of early screening of Alzheimer's disease. Early diagnosis through screening may enhance the family member's transition to a family caregiver and reduce caregiver burden by providing an opportunity for the family member to learn about the syndrome, receive interventions, and to prepare for their new care giving role.
Interventions
- BEHAVIORAL Collaborative Dementia Care Program
- OTHER Screening Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,822 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03300180
The ClinicalTrials.gov registry entry for NCT03300180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,822 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collaborative Dementia Care Program is the first listed.
NCT03300180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03300180 about?
NCT03300180 is a clinical study titled "Caregiver Outcomes of Alzheimer's Disease Screening". This study will measure the risks and benefits of early screening of Alzheimer's disease. Early diagnosis through screening may enhance the family member's transition to a family caregiver and reduce caregiver burden by providing an opportunity for the family member to learn about the syndrome, rece...
What is the current status of trial NCT03300180?
This trial is currently completed. It is a NA study. The enrollment target is 1,822 participants. The study started on 2018-10-15. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT03300180?
The interventions under investigation include: Collaborative Dementia Care Program (BEHAVIORAL), Screening Only (OTHER).
Who is sponsoring clinical trial NCT03300180?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.